SCHEMBL10072846

SCHEMBL10072846

B[C@@H]1O[C@H](CO)[C@@H](C)[C@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14643902 0.87 — —
SCHEMBL12769537 0.87 L3MBTL1 (0.31) —
SCHEMBL12049857 0.87 L3MBTL1 (0.31) —
SCHEMBL10072851 0.85 — —
SCHEMBL18267339 0.83 — —
SCHEMBL12583008 0.83 L3MBTL1 (0.33) —
SCHEMBL13818671 0.83 L3MBTL1 (0.33) —
SCHEMBL19146269 0.83 — —
SCHEMBL21563220 0.83 LGALS8 (0.31) —
SCHEMBL20654927 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8648054-B2 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication ROCHE PALO ALTO LLC (US) 2014-02-11 — — US disclosed
US-20130237491-A1 4'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION ROCHE PALO ALTO LLC (US) 2013-09-12 — — US disclosed
US-20120034184-A1 4'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION DEVOS RENE ROBERT (GB) 2012-02-09 — — US disclosed
Send feedback